Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Infections human papillomavirus

Human papillomavirus infection External genital warts... [Pg.520]

Ll. Lorinez, A. T., Reid, R., Jenson, A. B., Green, M. D., Lancaster, W., and Kurman, R. J., Human papillomavirus infection of the cervix Relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79, 328-337 (1992). [Pg.71]

Garcia-Lopez, P., Coll, M., Cervera, E., Reyes-Vermot, L., Torres, M. A., Abrego-Perez, G., Hernandez-Pajaro, A. I., Castaneda-HernAndez, G., Mohar-Betancourt, A., and Meneses, A. (2006), The systemic absorption of etoposide after intravaginal administration in patients with cervical intraepithelial lesions associated with human papillomavirus infection, Pharm. Res., 23, 378-383. [Pg.876]

Gunter J. Genital and perianal warts new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol 2003 189 S3-11. [Pg.1582]

Human Papillomavirus Infection Vaginal, urethral meatus, and anal warts... [Pg.2115]

Zanotii KM, Belinson J. Update on the diagnosis and treatment of human papillomavirus infection. Oeve Qin J Med 2002 69 948-961. [Pg.2117]

Zaki SR, Judd R, Coffield LM, et al. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol. 1992 140 1345-1355. [Pg.82]

Nonogaki S, Wakamatsu A, Filho AL, et al. Molecular strategies for identifying human papillomavirus infection in routinely processed samples focus on paraffin sections. / Low Genit Tract D .2005 9(4) 219-224. [Pg.285]

Fujita S, Senba M, Kumatori A, et al. Human papillomavirus infection in oral verrucous carcinoma genotyping analysis and inverse correlation with p53 expression. Pathobiology. 2008 75(4) 257-264. [Pg.285]

Pintos J, Black MJ, Sadeghi N, et al. Human papillomavirus infection and oral cancer A case-control study in Montreal, Canada. Oral Oncol. 2008 44(3) 242-250. [Pg.285]

Masumoto N, Pujii T, Ishikawa M, et al. pl6 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol. 2003 34 778-783. [Pg.337]

Ishikawa M, Fujii T, Masumoto N, et al. Correlation of pl6INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int Gynecol Pathol. 2003 22 378-385. [Pg.746]

Xu JY, Hashi A, Kondo T, et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol. 2005 24 296-302. [Pg.748]

Pientong C, Ekalaksananan T, Kongyingyoes B, et al. Immunocytochemical staining of pl6INK4a protein from conventional Pap test and its association with human papillomavirus infection. Diagn Cytopathol. 2004 31 235-242. [Pg.917]

Birner P, Bachtiary B, Dreier B, et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol. 2001 14 702-709. [Pg.918]

Barr BB, Benton EC, McLaren K et al (1989) Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2 224-225... [Pg.174]

Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M (2002) A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94 1406-1414... [Pg.175]

Infection risk Disseminated human papillomavirus infection developed in a patient during efalizumab therapy for psoriasis [128 ]. [Pg.592]

Shrestha NK, Hamrock DJ. Successful treatment of disseminated human papillomavirus infection with pegylated interferon and ribavirin. Clin Infect Dis 2010 51(1) e4-6. [Pg.604]

Koshiol J, Lindsay L, Pimenta JM et al. (2008) Persistent human papillomavirus infection and cervical neoplasia a systematic review and meta-analysis. Am J Epidemiol 168 123-137... [Pg.151]

Romney SL, Ho GY, Palan PR, Basu J, Kadish AS, Klein S, Mikhail M, Hagan RJ, Chang CJ, Burk RD (1997) Effects of p-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 65 483-492... [Pg.58]

Boggs SD, Cobb JD, Gudmundsson KS, Jones LA, Mat-suoka RT, Millar A, Patterson DE, Samano V, Trone MD, Xie S, Zhou X M. Efficient asymmetric synthesis of N-[(lR)-6-Chloro-2,3,4,9-tetrahydro-1 H-carbazol-1 -yl] -2-pyri-dinecarboxamide for treatment of human papillomavirus infections. Org. Process Res. Dev. 2007 ll(3) 539-545. [Pg.1208]

Sisk, E.A. and Robertson, E.S. (2002). Clinical implications of human papillomavirus infection. Front. Biosci. 7, e77-84. [Pg.356]

See other pages where Infections human papillomavirus is mentioned: [Pg.356]    [Pg.547]    [Pg.292]    [Pg.451]    [Pg.92]    [Pg.903]    [Pg.807]    [Pg.835]    [Pg.2221]    [Pg.212]   
See also in sourсe #XX -- [ Pg.2114 , Pg.2115 , Pg.2115 ]

See also in sourсe #XX -- [ Pg.252 ]



SEARCH



Human infection

Human papillomavirus

Human papillomaviruses

Papillomavirus

© 2024 chempedia.info